Trial · NCT07884474
Registered outcomes26
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 26
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Enrollment Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants approached that enroll in the study |
| Primary | Saliva Sampling Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants who complete the saliva sampling procedures will adhere to the timing of the saliva sampling |
| Primary | Blood Sampling Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants enrolled who complete the blood sample collection |
| Primary | Hair Sampling Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants enrolled that completed the hair sample collection |
| Primary | Fingernail Sampling Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants enrolled that completed the fingernail sample collection |
| Primary | Overall Study Procedure Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants enrolled that completed each study procedure |
| Secondary | Saliva Sampling Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of saliva sampling acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of intervention acceptability. |
| Secondary | Blood Sampling Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of blood sampling acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of intervention acceptability. |
| Secondary | Hair Sampling Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of hair sampling acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of intervention acceptability. |
| Secondary | Fingernail Sampling Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of fingernail sampling acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of intervention acceptability. |
| Secondary | Overall Biospecimen Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of overall biospecimen acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of intervention acceptability. |
| Secondary | Overall Study Procedure Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of overall study acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of overall study acceptability. |
| Secondary | Neighborhood Socioeconomic Status (nSES) | Post study, approximately 6 months after accrual ends | Determine whether neighborhood socioeconomic status (nSES), operationalizing using participants' address histories to estimate long-term neighborhood conditions, is associated with cortisol awakening response. Cortisol awakening response will be measured via the slope of four morning saliva samples (upon waking, +30 minutes, +45 minutes, +60 minutes) across three days, with values at each time point averaged across days. |
| Secondary | Neighborhood Socioeconomic Status (nSES) and Cortisol Diurnal Rhythm | Post study, approximately 6 months after accrual ends | Determine whether neighborhood socioeconomic status (nSES), operationalizing using participants' address histories to estimate long-term neighborhood conditions, is associated with cortisol diurnal rhythm. Cortisol diurnal rhythm will be measured via the slope of five daily saliva samples (upon waking, +30 minutes, +45 minutes, +60 minutes, bedtime) across three days, with values at each time point averaged across days. |
| Secondary | Neighborhood Socioeconomic Status (nSES) and Hair Cortisol Concentration | Post study, approximately 6 months after accrual ends | Determine whether neighborhood socioeconomic status (nSES), operationalizing using participants' address histories to estimate long-term neighborhood conditions, is associated with hair cortisol concentration. Hair cortisol concentration will be evaluated as a continuous measure. |
| Secondary | Neighborhood Socioeconomic Status (nSES) and Nail Cortisol Concentration | Post study, approximately 6 months after accrual ends | Determine whether neighborhood socioeconomic status (nSES), operationalizing using participants' address histories to estimate long-term neighborhood conditions, is associated with nail cortisol concentration. Nail cortisol concentration will be evaluated as a continuous measure. |
| Secondary | Neighborhood Socioeconomic Status (nSES) and High-Sensitivity C-Reactive Protein (hs-CRP) | Post study, approximately 6 months after accrual ends | Determine whether neighborhood socioeconomic status (nSES), operationalizing using participants' address histories to estimate long-term neighborhood conditions, is associated with high-sensitivity c-reactive protein (hs-CRP). Plasma hs-CRP will be evaluated as a continuous measure. |
| Secondary | Neighborhood Socioeconomic Status (nSES) and Interferon gamma (IFN-y) | Post study, approximately 6 months after accrual ends | Determine whether neighborhood socioeconomic status (nSES), operationalizing using participants' address histories to estimate long-term neighborhood conditions, is associated with interferon gamma (IFN-y). Plasma IFN-y will be evaluated as a continuous measure. |
| Secondary | Neighborhood Socioeconomic Status (nSES) and Interleukin 1 beta (IL-1β) | Post study, approximately 6 months after accrual ends | Determine whether neighborhood socioeconomic status (nSES), operationalizing using participants' address histories to estimate long-term neighborhood conditions, is associated with interleukin 1 beta (IL-1β). Plasma IL-1β will be evaluated as a continuous measure. |
| Secondary | Neighborhood Socioeconomic Status (nSES) and Interleukin 2 (IL-2) | Post study, approximately 6 months after accrual ends | Determine whether neighborhood socioeconomic status (nSES), operationalizing using participants' address histories to estimate long-term neighborhood conditions, is associated with interleukin 2 (IL-2). Plasma IL-2 will be evaluated as a continuous measure. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07884474/registered